Vaccines

SPOTLIGHT: Analyst lengthens timeline for Cervarix

A Morgan Stanley analyst is raising the prospect that GlaxoSmithKline's Cervarix could be delayed five years beyond the 2009 approval expected by most analysts on Wall Street. Report

GSK's Shingrix supply will leap up, CEO says—in 2024, that is

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

by Eric Sagonowsky Nov 15, 2019 10:26am

Vaccines

Merck makes history with world's first Ebola shot approval

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

by Eric Sagonowsky Nov 11, 2019 2:54pm

Vaccines

Cosette to add liquids to its mix with deal for 2nd plant

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

by Eric Palmer Nov 7, 2019 9:48am

Vaccines

SPOTLIGHT: Analyst lengthens timeline for Cervarix

Suggested Articles

GSK's Shingrix supply will leap up, CEO says—in 2024, that is

Merck makes history with world's first Ebola shot approval

Cosette to add liquids to its mix with deal for 2nd plant